| Dr Hector L Torres, MD | |
|
Ave Munoz Marin 53, Humacao, PR 00791-3646 | |
| (787) 850-3044 | |
| Not Available |
| Full Name | Dr Hector L Torres |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | Ave Munoz Marin 53, Humacao, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215927256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | ACN952 (Florida) | Primary |
| 174400000X | Specialist | 6244 (Puerto Rico) | Secondary |
| Entity Name | Professional Psychiatric Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679562797 PECOS PAC ID: 4981901444 Enrollment ID: O20160328001943 |
News Archive
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that the launch of Soliris (eculizumab) as a treatment for patients with PNH in Japan will begin in the third quarter of 2010, approximately three months earlier than previously expected.
To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.
Scientists know that Vitamin D deficiency is not healthy. However, new research from the University of Copenhagen now indicates that too high a level of the essential vitamin is not good either. The study is based on blood samples from 247,574 Copenhageners. The results have just been published in the reputed scientific Journal of Clinical Endocrinology and Metabolism.
In order to preserve first-line drugs for treating malaria, multiple combination therapies should be deployed within a population to prevent resistance from developing, according to Maciej Boni from the Centre for Tropical Medicine and Global Health, University of Oxford, UK, and colleagues in a Policy Forum article published in this week's PLOS Medicine.
Lupin Pharmaceuticals, Inc. has announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hector L Torres, MD 53 Calle Munoz Marin, Humacao, PR 00791-3646 Ph: (787) 850-3044 | Dr Hector L Torres, MD Ave Munoz Marin 53, Humacao, PR 00791-3646 Ph: (787) 850-3044 |
News Archive
Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that the launch of Soliris (eculizumab) as a treatment for patients with PNH in Japan will begin in the third quarter of 2010, approximately three months earlier than previously expected.
To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.
Scientists know that Vitamin D deficiency is not healthy. However, new research from the University of Copenhagen now indicates that too high a level of the essential vitamin is not good either. The study is based on blood samples from 247,574 Copenhageners. The results have just been published in the reputed scientific Journal of Clinical Endocrinology and Metabolism.
In order to preserve first-line drugs for treating malaria, multiple combination therapies should be deployed within a population to prevent resistance from developing, according to Maciej Boni from the Centre for Tropical Medicine and Global Health, University of Oxford, UK, and colleagues in a Policy Forum article published in this week's PLOS Medicine.
Lupin Pharmaceuticals, Inc. has announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.
› Verified 6 days ago
Mr. Reinaldo J Rodriguez Cruz, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 128 Calle Font Martelo Este, Humacao, PR 00791 Phone: 787-850-8382 Fax: 787-850-8388 | |
Angel Loyola, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 65 Calle Carreras E, Humacao, PR 00791 Phone: 787-852-3787 | |
Dr. Zulma Nanette Rodriguez, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9 Calle Flor Gerena N, Humacao, PR 00791 Phone: 787-850-5810 Fax: 787-850-5810 | |
Dr. Marta Medina, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Humacao Medical Plaza Ave. Font Martelo 53 Suite 203, Humacao, PR 00791 Phone: 787-285-1270 Fax: 787-285-1970 | |
Mary Karen Pena, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 334 Ave Font Martelo, Humacao, PR 00791 Phone: 787-852-0886 Fax: 787-852-0280 | |
Dr. Carlos O. Perez-cortes, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Ave. Font Martelo # 355, Hospital Ryder Office 403, Humacao, PR 00791 Phone: 787-852-2415 Fax: 787-850-0471 |